SWAlexander
Senior Member
- Messages
- 1,508
Summary: A new study paves the way for potential treatments for Multiple Sclerosis (MS) by identifying the OTC antihistamine, clemastine, as an effective drug for brain repair. Utilizing a newly-developed MRI scan technique, scientists were able to observe and measure the impact of clemastine on brain myelin levels.
The study offers the first documented example of brain repair for a chronic neurological condition through MRI. These results are expected to set a standard for future research into myelin-rebuilding therapies.
https://neurosciencenews.com/antihistamine-myelin-multiple-sclerosis-23453/
Other publication on antihistamine and MS:
Over-the-counter antihistamine repairs nerve damage caused by MS.
https://newatlas.com/medical/antihistamine-reverses-ms-nerve-damage/
MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial
https://www.pnas.org/doi/10.1073/pnas.2217635120
Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis https://www.pnas.org/doi/full/10.1073/pnas.1821306116
Clemastine, an Food and Drug Administration-approved antihistamine drug, reduces inflammation, protects cells, promotes remyelination, and preserves myelin integrity. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827778/
The study offers the first documented example of brain repair for a chronic neurological condition through MRI. These results are expected to set a standard for future research into myelin-rebuilding therapies.
https://neurosciencenews.com/antihistamine-myelin-multiple-sclerosis-23453/
Other publication on antihistamine and MS:
Over-the-counter antihistamine repairs nerve damage caused by MS.
https://newatlas.com/medical/antihistamine-reverses-ms-nerve-damage/
MWF of the corpus callosum is a robust measure of remyelination: Results from the ReBUILD trial
https://www.pnas.org/doi/10.1073/pnas.2217635120
Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis https://www.pnas.org/doi/full/10.1073/pnas.1821306116
Clemastine, an Food and Drug Administration-approved antihistamine drug, reduces inflammation, protects cells, promotes remyelination, and preserves myelin integrity. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827778/